2-Chloro-1-(difluoromethoxy)-3-nitrobenzene, 97%, 250mg

Sodium hydrogen carbonate, min. 99%, 500 g, plastic packaging.

(7R,8aS)-2-benzyl-7-hydroxy-octahydropyrrolo[1,2-a]piperazine-1,4-dione, 95.0%, 1g

N-methyl-N-((3R,4S)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine compound with N-methyl-N-((3S,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine(1:1), 98%, 10mg

1,4,7-Tris(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane, 100mg

(1S,3R,4S)-4-(2-((5-CHLOROPYRIDIN-2-YL)AMINO)-2-OXOACETAMIDO)-3-(5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDO)CYCLOHEXANE-1-CARBOXYLIC ACID, 95%, 5mg

Cyclopropylmethyl-methyl-amine hydrochloride, 95.0%, 500mg

N-(tert-Butyl)-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide, 97%, 1g

Methyl 4'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,1'-biphenyl]-3-carboxylate, 96%, 1g

3,3''-Dibromo-1,1':3',1''-terphenyl, 97%, 10g

1H-Pyrazol-5(4H)-one, 95.0%, 10g

1-(Phenylmethyl)-4-(3-carboxycyclobutyl)-1-piperidinecarboxylate, 95%, 250mg

5-Bromo-2-fluorophenol, 97.0%, 10g